Common variants on cytotoxic T lymphocyte antigen-4 polymorphisms contributes to type 1 diabetes susceptibility: Evidence based on 58 studies

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Wang, Jingnan ^a   Liu, Lianyong ^a   Ma, Junhua ^a   Sun, Fei ^a   Zhao, Zefei ^a   Gu, Mingjun ^a  

^a Shanghai Pudong New Area Gongli Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GUANINE; THYMINE;

ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CTLA4 GENE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DOMINANT INHERITANCE; ETHNIC DIFFERENCE; ETHNICITY; EVIDENCE BASED MEDICINE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); POPULATION BASED CASE CONTROL STUDY; RECESSIVE INHERITANCE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE;

CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84899845615     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085982     Document Type: Article

References (73)

1. Eisenbarth GS (2007) Update in type 1 diabetes. J Clin Endocrinol Metab 92:2403-2407.
2. Walunas TL, Bakker CY, Bluestone JA (1996) CTLA4 ligation blocks CD28-dependent T cell activation. J Exp Med 183: 2541-2550. (Pubitemid 26192364)
3. Lane P (1997) Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86. Ann NY Acad Sci 815: 392-400.
4. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129.
5. Thompson SG, Shar SJ (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18: 2693-2708. (Pubitemid 29481404)
6. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188. (Pubitemid 17189972)
7. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634. (Pubitemid 27387172)
8. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, et al. (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5: 1075-1080.
9. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, et al. (1997) CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82: 143-146. (Pubitemid 27021285)
10. Van der Auwera BJ, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, et al. (1997) CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clin Exp Immunol 110: 98-103. (Pubitemid 27428521)
11. Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, et al. (1998) Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 47: 128-129. (Pubitemid 28030819)
12. Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, et al. (1998) No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 47: 125-127. (Pubitemid 28030818)
13. Krokowski M, Bodalski J, Bratek A, Machejko P, Caillat-Zucman S (1998) CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland. Diabetes Metab 24: 241-243. (Pubitemid 28290090)
14. Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, et al. (1999) CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res Clin Pract 46: 169-175. (Pubitemid 29509926)
15. Hayashi H, Kusaka I, Nagasaka S, Kawakami A, Rokkaku K, et al. (1999) Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus. Clin Endocrinol (Oxf) 51: 793-799. (Pubitemid 30050831)
16. Yanagawa T, Maruyama T, Gomi K, Taniyama M, Kasuga A, et al. (1999) Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects. Autoimmunity 29: 53-56. (Pubitemid 29097572)
17. Lee YJ, Huang FY, Lo FS, Wang WC, Hsu CH, et al. (2000) Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clin Endocrinol (Oxf) 52: 153-157. (Pubitemid 30108260)
18. Takara M, Komiya I, Kinjo Y, Tomoyose T, Yamashiro S, et al. (2000) Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care 23: 975-978. (Pubitemid 30480026)
19. Ihara K, Ahmed S, Nakao F, Kinukawa N, Kuromaru R, et al. (2001) Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 53: 447-454. (Pubitemid 32906984)
20. Kamoun Abid H, Hmida S, Smaoui N, Kaabi H, Abid A, et al. (2001) Association between type 1 diabetes and polymorphism of the CTLA-4 gene in a Tunisian population. Pathol Biol (Paris) 49: 794-798. (Pubitemid 33130950)
21. Kikuoka N, Sugihara S, Yanagawa T, Ikezaki A, Kim HS, et al. (2001) Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies. Clin Endocrinol (Oxf) 55: 597-603. (Pubitemid 34204442)
22. McCormack RM, Maxwell AP, Carson D, Patterson CC, Bingham A, et al. (2001) Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population. Genes Immun 2: 233-235. (Pubitemid 33676989)
23. Osei-Hyiaman D, Hou L, Zhiyin R, Zhiming Z, Yu H, et al. (2001) Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese. Diabetes 50: 2169-2171. (Pubitemid 33643688)
24. Cinek O, Drevínek P, Sumník Z, Bendlová B, Kolousková S, et al. (2002) The CTLA4 +49 A/G dimorphism is not associated with type 1 diabetes in Czech children. Eur J Immunogenet 29: 219-222. (Pubitemid 34621795)
25. Cosentino A, Gambelunghe G, Tortoioli C, Falorni A (2002) CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann N Y Acad Sci 958: 337-340. (Pubitemid 34592258)
26. Fajardy I, Vambergue A, Stuckens C, Weill J, Danze PM, et al. (2002) CTLA-4 49 A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect. Eur J Immunogenet 29: 251-257. (Pubitemid 34621800)
27. Klitz W, Bugawan TL, Panelo A, Solfelix CM, Buzzetti R, et al. (2002) Association of CTLA-4 variation with type I diabetes in Filipinos. Immunogenetics 54: 310-313. (Pubitemid 34983948)
28. Ma Y, Tang X, Chang W, Gao L, Li M, et al. (2002) CTLA-4 gene A/G polymorphism associated with diabetes mellitus in Han Chinese. Chin Med J (Engl) 115: 1248-1250. (Pubitemid 34947353)
29. Ongagna JC, Sapin R, Pinget M, Belcourt A (2002) Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes. Int J Exp Diabetes Res 3: 1-9. (Pubitemid 35174540)
30. Wood JP, Pani MA, Bieda K, Meyer G, Usadel KH, et al. (2002) A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes. Eur J Immunogenet 29: 347-349. (Pubitemid 34779676)
31. Bouqbis L, Izaabel H, Akhayat O, Pérez-Lezaun A, Calafell F, et al. (2003) Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun 4: 132-137. (Pubitemid 38967587)
32. Mochizuki M, Amemiya S, Kobayashi K, Kobayashi K, Shimura Y, et al. (2003) Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 26: 843-847. (Pubitemid 36929353)
33. Haller K, Kisand K, Nemvalts V, Laine AP, Ilonen J, et al. (2004) Type 1 diabetes is insulin -2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur J Clin Invest 34: 543-548. (Pubitemid 39120223)
34. Ide A, Kawasaki E, Abiru N, Sun F, Kobayashi M, et al. (2004) Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 22: 73-78. (Pubitemid 38050215)
35. Liang H, Yagi K, Asano A, Kobayashi J, Mabuchi H (2004) Association between CTLA-4 +49 A/G polymorphism and type 1B diabetes in Japanese population. Endocrine 25: 105-109. (Pubitemid 41271135)
36. Zalloua PA, Abchee A, Shbaklo H, Zreik TG, Terwedow H, et al. (2004) Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Hum Immunol 65: 719-724. (Pubitemid 39061169)
37. Caputo M, Cerrone GE, López AP, Villalba A, Krochik GA, et al. (2005) Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA). Autoimmunity 38: 277-281. (Pubitemid 40974957)
38. Mojtahedi Z, Omrani GR, Doroudchi M, Ghaderi A (2005) CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians. Diabetes Res Clin Pract 68: 111-116. (Pubitemid 40602617)
39. Zhernakova A, Eerligh P, Barrera P, Wesoly JZ, Huizinga TW, et al. (2005) CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum Genet 118: 58-66.
40. Ahmedov G, Ahmedova L, Sedlakova P, Cinek O (2006) Genetic association of type 1 diabetes in an Azerbaijanian population: the HLA-DQ, -DRB1*04, the insulin gene, and CTLA4. Pediatr Diabetes 7: 88-93.
41. Baniasadi V, Narain N, Goswami R, Das SN (2006) Promoter region -318 C/T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 67: 383-389.
42. Kanazawa Y, Motohashi Y, Yamada S, Oikawa Y, Shigihara T, et al. (2006) Frequency of CTLA-4 gene CT60 polymorphism may not be affected by vitamin D receptor gene Bsm I polymorphism or HLA DR9 in autoimmune-related type 1 diabetes in the Japanese. Ann N Y Acad Sci 1079: 251-256.
43. Ikegami H, Awata T, Kawasaki E, Kobayashi T, Maruyama T, et al. (2006) The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab 91: 1087-1092. (Pubitemid 43357785)
44. Haller K, Kisand K, Pisarev H, Salur L, Laisk T, et al. (2007) Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens 69: 121-127. (Pubitemid 46174865)
45. Howson JM, Dunger DB, Nutland S, Stevens H, Wicker LS, et al. (2007) A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 50: 741-746. (Pubitemid 46355837)
46. Butty V, Campbell C, Mathis D, Benoist C (2008) Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). Diabetes 57: 2348-2359.
47. Kawasaki E, Imagawa A, Makino H, Uga M, Abiru N, et al. (2008) Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care 31: 1608-1610.
48. Saleh HM, Rohowsky N, Leski M (2008) The CTLA4 -819 C/T and +49 A/G dimorphisms are associated with Type 1 diabetes in Egyptian children. Indian J Hum Genet 14: 92-98.
49. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, et al. (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359: 2767-2777.
50. Balic I, Angel B, Codner E, Carrasco E, Perez-Bravo F (2009) Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum Immunol 70: 116-120.
51. Douroudis K, Laine AP, Heinonen M, Hermann R, Lipponen K, et al. (2009) Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum Immunol 70: 536-539.
52. Jin P, Xiang B, Lin J, Huang G, Zhou WD, et al. (2009) Association of CTLA-4 + 49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity. Zhonghua Yi Xue Za Zhi 89: 1246-1249.
53. Jung MH, Yu J, Shin CH, Suh BK, Yang SW, et al. (2009) Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms and HLA class II alleles with the development of type 1 diabetes in Korean children and adolescents. J Korean Med Sci 24: 1004-1009.
54. Korolija M, Renar IP, Hadzija M, Medvidović EP, Pavković P, et al. (2009) Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with Type 1 Diabetes in Croatians. Diabetes Res Clin Pract 86: e54-57.
55. Lemos MC, Coutinho E, Gomes L, Bastos M, Fagulha A, et al. (2009) The CTLA4 +49 A/G polymorphism is not associated with susceptibility to type 1 diabetes mellitus in the Portuguese population. Int J Immunogenet 36: 193-195.
56. Momin S, Flores S, Angel BB, Codner DE, Carrasco PE, et al. (2009) Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes. Diabetes Res Clin Pract 83: 289-294.
57. Benmansour J, Stayoussef M, Al-Jenaidi FA, Rajab MH, Rayana CB, et al. (2010) Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians. Clin Vaccine Immunol 17: 1473-1477.
58. Klinker MW, Schiller JJ, Magnuson VL, Wang T, Basken J, et al. (2010) Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects. Immunogenetics 62: 101-107.
59. Howson JM, Rosinger S, Smyth DJ, Boehm BO, Todd JA (2011) Genetic analysis of adult-onset autoimmune diabetes. Diabetes 60: 2645-2653.
60. Philip B, Isabel W (2011) Association of cytotoxic T lymphocyte- associated antigen 4 gene single nucleotide polymorphism with type 1 diabetes mellitus in Madurai population of Southern India. Indian J Hum Genet 17: 85-89.
61. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, et al. (2011) Genomewide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 7: e1002216.
62. Reddy MV, Wang H, Liu S, Bode B, Reed JC, et al. (2011) Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun 12: 208-212.
63. Ei Wafai RJ, Chmaisse HN, Makki RF, Fakhoury H (2011) Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes. Saudi J Kidney Dis Transpl 22: 273-281.
64. Horie I, Kawasaki E, Ando T, Kuwahara H, Abiru N, et al. (2012) Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population. J Clin Endocrinol Metab 97: E1043-1050.
65. Mosaad YM, Elsharkawy AA, El-Deek BS (2012) Association of CTLA-4 (+49A/G) Gene Polymorphism with Type 1 Diabetes Mellitus in Egyptian Children. Immunol Invest 41: 28-37.
66. Villano MJ, Huber AK, Greenberg DA, Golden BK, Concepcion E et al. (2009) Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J Clin Endocrinol Metab 94:1458-66.
67. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, et al. (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves disease. J Immunol 165: 6606-6611.
68. Ueda H, Howson JM, Esposito L, Heward J, Snook H, et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511. (Pubitemid 36648570)
69. Atabani SF, Thio CL, Divanovic S, Trompette A, Belkaid Y, et al. (2005) Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol 35:2157-2162. (Pubitemid 41015054)
70. Chen Z, Fei M, Fu D, Zhang L, Ma Y, et al. (2013) Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis. Gene 516:263-70.
71. Si X, Zhang X, Luo Y, Tang W (2012) Association between the CTLA-4 +49A/G polymorphism and type 1 diabetes: a meta-analysis. Genet Test Mol Biomarkers 16:1336-42.
72. Tang ST, Tang HQ, Zhang Q, Wang CJ, Wang YM, et al. (2012) Association of cytotoxic T-lymphocyte associated antigen 4 gene polymorphism with type 1 diabetes mellitus: a meta-analysis. Gene 508:165-87.
73. Chang WW, Zhang L, Su H, Jin YL, Chen Y, et al. (2012) Need for clarification of data in the recent meta-analysis about cytotoxic T-lymphocyte associated antigen 4 gene polymorphism and type 1 diabetes mellitus. Gene. doi: 10.1016/j.gene.2012.12.035.